News
Merck & Co reports Q1 earnings on Thursday with EPS of $2.14 and revenue of $15.33B expected. Despite a 38.04% drop in stock ...
Investor's Business Daily on MSN2d
Gardasil Sales Decline — Again. Can Dow Jones Stock Merck Take The Hit?Merck stock could take another hit Thursday after the company reported another quarter of light sales for its HPV vaccine, ...
Many investors are withdrawing their money from the stock market right now, but those focused on the long term know to hold ...
Shares of Merck & Co. Inc. MRK advanced 1.44% to $78.97 Tuesday, on what proved to be an all-around positive trading session ...
Merck is growing pharma sales and expanding margins, led by strong KEYTRUDA performance and cost discipline. Read more about ...
Julie Hyman provides an overview of the top stories of the trading day in just 60 seconds on Yahoo Finance's Market Minute. Merck & Company (MRK) warns investors that it expects a $200 million hit ...
The stock's rise snapped a three-day losing streak.
MERCK & CO INC (MRK) is a large-cap value stock in the Biotechnology & Drugs industry. The rating using this strategy is 100% based on the firm’s underlying fundamentals and the stock’s ...
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas ...
Merck lowered its full-year profit guidance and said tariffs would mean an extra $200 million in costs this year. The stock ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback